As obesity pioneer Novo Nordisk loses ground in the race for next-generation drugs, the Danish pharma giant is betting on…

Mere months after its cancer blockbuster hopeful topped Bayer’s Stivarga in a phase 3 trial, Exelixis is conducting a reorganization…

In the heart of Malaysia’s diverse landscape lies Sarawak, a state grappling with one of the highest incidence rates of…

A sweeping international review led by researchers at Flinders University reveals significant demographic shifts and emerging health challenges in childbirth…

In the current landscape of healthcare, the opioid crisis continues to pose significant challenges to both medical professionals and the…

In the ever-evolving field of oncology, understanding the intricate relationship between the immune system and cancer progression has become pivotal.…

In a groundbreaking study led by a team of researchers including Yang, J., Wang, M., and Zhou, D., significant advancements…

Peptidyl-arginine deiminase 2 (PAD2) has emerged as a pivotal enzyme driving the progression of pancreatic ductal adenocarcinoma (PDAC), one of…

In recent years, the landscape of medical technology has profoundly shifted, particularly in the realm of cardiovascular devices. A critical…

In a groundbreaking study published in the European Geriatric Medicine journal, researchers led by Oliveira et al. have delved into…